According to the package insert of the direct Xa inhibitor, in the case of venous thromboembolism in patients undergoing lower limb orthopedic surgery, the first administration should be performed 12 h after surgery and after confirming that there is no bleeding from surgical wounds. The gene discussed is TNXA; the disease is venous thromboembolism.